Skip to main content
. 2017 Mar 21;3(1):11–20. doi: 10.1016/j.ijwd.2017.01.004

Table 2.

Proposed pretreatment regimen

Two to Six Weeks Pretreatment Control of risk factors (sunprotection, discontinue hormone treatments) with:
  • -

    Topical anti-Tyrosinase therapy daily

  • -

    Other inhibitors of the melanin synthetic pathway (e.g., protease-activated receptor-2 inhibitor)